G1 Therapeutics, Inc. Gains 66.12%

Wed, Aug 07, 2024 at 07:12 PM

G1 Therapeutics, Inc. (GTHX:NASDAQ) jumped higher at $7.06, a gain of 66.1%. On Wed, Aug 07, 2024, GTHX:NASDAQ touched a New 2-Week High of $7.06. The stock got featured on our News Catalysts scanner on Wed, Aug 07, 2024 at 07:24 AM in the 'ACQUISITION' category. From Wed, Jul 24, 2024, the stock recorded 50.00% Up Days and 45.45% Green Days

About G1 Therapeutics, Inc. (GTHX:NASDAQ)

G1 Therapeutics Inc is a clinical-stage biopharmaceutical company. It engages in developing novel, small-molecule therapies to target significant unmet needs to treat cancer.

Top 10 Gainers:

Republic First Bancorp, Inc. (FRBK:NASDAQ), 122.22%
Richtech Robotics Inc. (RR:NASDAQ), 67.14%
Vinco Ventures Inc. (BBIG:NASDAQ), 66.67%
G1 Therapeutics, Inc. (GTHX:NASDAQ), 66.12%
Greenlane Holdings, Inc. (GNLN:NASDAQ), 58.2%
PetIQ, Inc. (PETQ:NASDAQ), 47.89%
Power REIT (PW:NYSEMKT), 46.51%
Latham Group Inc. (SWIM:NASDAQ), 41.48%
Upstart Holdings Inc. (UPST:NASDAQ), 39.51%
Color Star Technology Co. Ltd. (ADD:NASDAQ), 39.33%